Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-14-001611
Filing Date
2014-11-14
Accepted
2014-11-14 13:03:56
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 AOXING PHARMACEUTICAL COMPANY, INC. 10Q 2014-09-30 aoxing.htm 10-Q 478885
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SOX OF 2 aoxingexh311.htm EX-31.1 8867
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SOX OF 2 aoxingexh312.htm EX-31.2 9235
4 CERTIFICATE OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.SS.1350. aoxingexh321.htm EX-32.1 5308
5 CERTIFICATE OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.SS.1350. aoxingexh322.htm EX-32.2 5401
  Complete submission text file 0001096906-14-001611.txt   3175458

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT axn-20140930.xml EX-101.INS 460493
7 XBRL SCHEMA DOCUMENT axn-20140930.xsd EX-101.SCH 30983
8 XBRL CALCULATION LINKBASE DOCUMENT axn-20140930_cal.xml EX-101.CAL 20176
9 XBRL DEFINITION LINKBASE DOCUMENT axn-20140930_def.xml EX-101.DEF 37488
10 XBRL LABELS LINKBASE DOCUMENT axn-20140930_lab.xml EX-101.LAB 143171
11 XBRL PRESENTATION LINKBASE DOCUMENT axn-20140930_pre.xml EX-101.PRE 133035
Mailing Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310
Business Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310 646-367-1747
AOXING PHARMACEUTICAL COMPANY, INC. (Filer) CIK: 0001060426 (see all company filings)

EIN.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-32674 | Film No.: 141222362
SIC: 2834 Pharmaceutical Preparations